XML 141 R121.htm IDEA: XBRL DOCUMENT
v3.23.3

Financial Instruments (Tables) | 9 Months Ended | 12 Months Ended
--- | --- | ---
Sep. 30, 2023 | Dec. 31, 2022
Fair Value Disclosures [Abstract] |  |
Schedule of changes in the level 3 fair value of warrant liabilities | The following tables summarize the changes in fair value of our outstanding earnout liability in the nine months ended September 30, 2023. The warrant and earnout liability were not present in the nine months ended September 30, 2022. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Fair Value at |  | Change in |  | ​ | ​ |  | Net Transfer |  | Fair Value at
Level 3 | ​ | December 31, | ​ | Unrealized | ​ | Issuances | ​ | In (Out) of | ​ | September 30,
Liabilities | ​ | 2022 | ​ | (Gains) Losses | ​ | (Settlements) | ​ | Level 3 | ​ | 2023
Contingent earnout liability | ​ | $ | — | ​ | $ | (19,904) | ​ | $ | 28,927 | ​ | $ | — | ​ | $ | 9,023
The following tables summarize the changes in fair value of our outstanding warrant and tranche liabilities measured using Level 3 inputs in the nine months ended September 30, 2023 and 2022: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Fair Value at |  | Change in |  | ​ | ​ |  | Net Transfer |  | Fair Value at
Level 3 | ​ | December 31, | ​ | Unrealized | ​ | Issuances | ​ | In (Out) of | ​ | September 30,
Liabilities | ​ | 2021 | ​ | (Gains) Losses | ​ | (Settlements) | ​ | Level 3 | ​ | 2022
Warrant liability | ​ | $ | 391 | ​ | $ | (19) | ​ | $ | — | ​ | $ | — | ​ | $ | 372
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Fair Value at |  | Change in |  | ​ | ​ |  | Net Transfer |  | Fair Value at
Level 3 | ​ | December 31, | ​ | Unrealized | ​ | Issuances | ​ | In (Out) of | ​ | September 30,
Liabilities | ​ | 2022 | ​ | (Gains) Losses | ​ | (Settlements) | ​ | Level 3 | ​ | 2023
Warrant liability | ​ | $ | 369 | ​ | $ | — | ​ | $ | (369) | ​ | $ | — | ​ | $ | —
Series B-2 tranche liabilities | ​ | $ | 4,702 | ​ | $ | (3,200) | ​ | $ | (1,502) | ​ | $ | — | ​ | $ | —
Series B-3 Warrant liabilities | ​ | $ | 15,819 | ​ | $ | (311) | ​ | $ | (15,508) | (1) | $ | — | ​ | $ | —
(1) | This amount includes settlements of $25,409, and final net exercise of $4,800, transferred to convertible preferred stock, offset by issuances of $14,701
| ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value at | ​ | Change in | ​ | ​ | ​ | ​ | Net Transfer | ​ | Fair Value at
Level 3 | ​ | December 31, | ​ | Unrealized | ​ | Issuances | ​ | In (Out) of | ​ | December 31,
Liabilities |  | 2020 |  | (Gains) Losses |  | (Settlements) |  | Level 3 |  | 2021
Warrant liability | ​ | $ | 3,399 | ​ | $ | 379 | ​ | $ | (3,387) | (1) | $ | — | ​ | $ | 391
Put option liability | ​ | $ | 5,140 | ​ | $ | 70 | ​ | $ | (5,210) | ​ | $ | — | ​ | $ | —
​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fair Value at | ​ | Change in | ​ | ​ | ​ | ​ | Net Transfer | ​ | Fair Value at
Level 3 | ​ | December 31, | ​ | Unrealized | ​ | Issuances | ​ | In (Out) of | ​ | December 31,
Liabilities |  | 2021 |  | (Gains) Losses |  | (Settlements) |  | Level 3 |  | 2022
Warrant liability | ​ | $ | 391 | ​ | $ | (22) | ​ | $ | — | ​ | $ | — | ​ | $ | 369
Series B-2 tranche liabilities | ​ | $ | — | ​ | $ | (1,645) | ​ | $ | 6,347 | ​ | $ | — | ​ | $ | 4,702
Series B-3 warrant liabilities | ​ | $ | — | ​ | $ | 3,853 | ​ | $ | 11,966 | ​ | $ | — | ​ | $ | 15,819
​ (1)This amount includes settlements of $3,397, reduced by issuances of $10.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration